Rare Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Children under 18 years old.
- People with a confirmed or suspected diagnosis of FHL (Familial Hemophagocytic Lymphohistiocytosis) or a related genetic condition that increases the risk of HLH (such as Griscelli Syndrome, Chédiak-Higashi Syndrome, XLP1, or XLP2), or a family history of a condition involving abnormal immune cell activation.
- People who meet at least 5 of the following 8 medical criteria, as defined by the Histiocyte Society: fever; an enlarged spleen; abnormally high fat levels or low fibrinogen (a clotting protein) in the blood; evidence of immune cells attacking blood cells, found in a tissue sample; reduced or absent natural killer (NK) cell activity; a ferritin (iron-related protein) level of 500 µg/l or above; elevated levels of a specific immune marker called soluble CD25, or the presence of activated immune cells detected through specialised blood testing; or low counts in at least two types of blood cells (red blood cells, platelets, or white blood cells).
- People covered by French social security.
- People whose legal guardian(s) have signed the informed consent form for the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People aged 18 or older.
- People who have a solid tumour, leukaemia, or lymphoma.
- People covered under specific articles of the French public health code, including those under guardianship or curatorship, those deprived of liberty, and women who are pregnant or breastfeeding.
- People who do not understand the French language.
- People currently within an exclusion period from another research study at the time the consent form is signed.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 04 91 38 98 21
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time (in days) from clinical suspicion to hematopoietic stem cell transplantation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.